Literature DB >> 10386577

Adaptive hypoxic tolerance in the subterranean mole rat Spalax ehrenbergi: the role of vascular endothelial growth factor.

A Avivi1, M B Resnick, E Nevo, A Joel, A P Levy.   

Abstract

Spalax ehrenbergi has evolved adaptations that allow it to survive and carry out normal activities in a highly hypoxic environment. A key component of this adaptation is a higher capillary density in some Spalax tissues resulting in a shorter diffusion distance for oxygen. Vascular endothelial growth factor (VEGF) is an angiogenic factor that is critical for angiogenesis during development and in response to tissue ischemia. We demonstrate here that VEGF expression is markedly increased in those Spalax tissues with a higher capillary density relative to the normal laboratory rat Rattus norvegicus. Upregulation of VEGF thus appears to be an additional mechanism by which Spalax has adapted to its hypoxic environment.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10386577     DOI: 10.1016/s0014-5793(99)00584-0

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  33 in total

1.  Reciprocal regulation of expression of pore-forming KATP channel genes by hypoxia.

Authors:  M Melamed-Frank; A Terzic; A J Carrasco; E Nevo; A Avivi; A P Levy
Journal:  Mol Cell Biochem       Date:  2001-09       Impact factor: 3.396

2.  The variable heartbeat of Japanese moles (Mogera spp.).

Authors:  Taiki Matsuo; Atsushi Kashimura; Naomi Wada
Journal:  J Comp Physiol B       Date:  2019-10-14       Impact factor: 2.200

3.  Adaptive evolution of heparanase in hypoxia-tolerant Spalax: gene cloning and identification of a unique splice variant.

Authors:  Nicola J Nasser; Eviatar Nevo; Itay Shafat; Neta Ilan; Israel Vlodavsky; Aaron Avivi
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-04       Impact factor: 11.205

4.  Restoration of blood flow by using continuous perimuscular infiltration of plasmid DNA encoding subterranean mole rat Spalax ehrenbergi VEGF.

Authors:  Ariel Roguin; Aaron Avivi; Samy Nitecki; Irit Rubinstein; Nina S Levy; Zaid A Abassi; Murray B Resnick; Orit Lache; Meira Melamed-Frank; Alma Joel; Aaron Hoffman; Eviatar Nevo; Andrew P Levy
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-02       Impact factor: 11.205

Review 5.  Tissue responses to ischemia: local and remote responses for preserving perfusion of ischemic muscle.

Authors:  J M Isner
Journal:  J Clin Invest       Date:  2000-09       Impact factor: 14.808

6.  Adaptive methylation regulation of p53 pathway in sympatric speciation of blind mole rats, Spalax.

Authors:  Yang Zhao; Jia-Wei Tang; Zhi Yang; Yi-Bin Cao; Ji-Long Ren; Yuval Ben-Abu; Kexin Li; Xue-Qun Chen; Ji-Zeng Du; Eviatar Nevo
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-08       Impact factor: 11.205

7.  Neuroglobin, cytoglobin, and myoglobin contribute to hypoxia adaptation of the subterranean mole rat Spalax.

Authors:  Aaron Avivi; Frank Gerlach; Alma Joel; Stefan Reuss; Thorsten Burmester; Eviatar Nevo; Thomas Hankeln
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-29       Impact factor: 11.205

8.  Placental growth factor reverses decreased vascular and uteroplacental MMP-2 and MMP-9 and increased MMP-1 and MMP-7 and collagen types I and IV in hypertensive pregnancy.

Authors:  Zongli Ren; Ning Cui; Minglin Zhu; Raouf A Khalil
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-03-23       Impact factor: 4.733

9.  The muscle ankyrin repeat proteins are hypoxia-sensitive: in vivo mRNA expression in the hypoxia-tolerant blind subterranean mole rat, Spalax ehrenbergi.

Authors:  Mark Band; Alma Joel; Aaron Avivi
Journal:  J Mol Evol       Date:  2009-12-05       Impact factor: 2.395

10.  An extracellular region of the erythropoietin receptor of the subterranean blind mole rat Spalax enhances receptor maturation.

Authors:  Orly Ravid; Imad Shams; Nathalie Ben Califa; Eviatar Nevo; Aaron Avivi; Drorit Neumann
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-27       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.